Dinh, A., Bleibtreu, A., Duran, C., Bouchand, F., Bosch, A., Crozon-Clauzel, J., . . . Group, o. b. o. t. M. F. S. (2024). National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa. Antibiotics, 13(12), 1152. https://doi.org/10.3390/antibiotics13121152

Dinh, Aurélien, et al. "National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas Aeruginosa." Antibiotics 13, no. 12 (2024): 1152. https://doi.org/10.3390/antibiotics13121152.

Dinh, Aurélien, et al. "National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas Aeruginosa." Antibiotics, vol. 13, no. 12, 2024, p. 1152, https://doi.org/10.3390/antibiotics13121152.